RetinalGeniX Technologies Inc (RTGN)

[~S.B.A.~]

WORLD HEALTH ORGANIZATION: ANTIMICROBIAL RESISTANCE Global Report on surveillance April 2014. The first ever report issued exposing the antimicrobial resistance crisis on a global scale. Modern medicine was enabled due in part to antibiotics. Current antibiotics are becoming resistant to the most common bacteria--> superbugs due to the overuse/misuse of antibiotics. Already, the news is filled with stories if unbelievable infections festering in hospitals which are deadly. Biotech has seen antibiotics as a minimal way to make profit, thus antibiotics are lacking. The WHOs goal of April release of the AMR report is to enable more institutional/retail monies into the antibiotic industry and the PREVENTION SIDE.


Report:
http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1


RTGN company overview and value proposition have a strikingly similar theme of prevention in accordance to the WHO report. As the WHO drums up national/global attention, we could be a direct beneficiary of the AMR campaign, thus many eyes watching this stock.